Back to Search
Start Over
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients
- Source :
- Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 33
- Publication Year :
- 2019
-
Abstract
- Background: Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease characterized by a significant impairment of patients’ quality of life (QoL). It has been recently found that clinical severity of HS does not correlate well with QoL. Therefore, it is important to enhance the evaluation of severity considering the disease burden on QoL. Recently, a new graphical tool able to better describe HS burden, the so-called HIDRAdisk, has been introduced. Objective: To investigate the utility of HIDRAdisk in clinical practice before and after treatment and to analyse whether specific factors such as age and gender may influence the outcomes in patients with moderate-to-severe HS. Methods: A single-centre retrospective study on 24 patients (13F/11M, mean age 38±15years) with moderate-to-severe HS was performed. Clinical data (disease severity and quality of life) were collected at baseline and after 12weeks of adalimumab. Results: HIDRAdisk showed significantly better improvements in males (69.8±6.2–49.6±10.8) compared to females (80.7±6.0–72.3±6.7), P&nbsp
- Subjects :
- Adult
Male
medicine.medical_specialty
Visual Analog Scale
Dermatology
Severity of Illness Index
Age and gender
030207 dermatology & venereal diseases
03 medical and health sciences
Young Adult
0302 clinical medicine
Sex Factors
Disease severity
Quality of life
Hidradenitis suppurativa, quality of life
Cost of Illness
Internal medicine
medicine
Adalimumab
Humans
In patient
Hidradenitis suppurativa
030212 general & internal medicine
Disease burden
Retrospective Studies
business.industry
Age Factors
Retrospective cohort study
Middle Aged
medicine.disease
Hidradenitis Suppurativa
Infectious Diseases
Treatment Outcome
Quality of Life
Female
business
Settore MED/35 - MALATTIE CUTANEE E VENEREE
HIDRAdisk outcomes
medicine.drug
hidradisk
Subjects
Details
- ISSN :
- 14683083
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Journal of the European Academy of Dermatology and Venereology : JEADVReferences
- Accession number :
- edsair.doi.dedup.....c8cd3ca9cb9b41350b1b5c9f83eea323